Поиск

Материалов:
980 144

Репозиториев:
30

Авторов:
596 024

Автор

Ключевое слово

Тип статьи

DOI

ORCID

Дополнительно:

Период публикации

Репозиторий

По вашему запросу найдено документов: 296373

Страница 1 из 29638

AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

Ivashchenko Andrey Alexandrovich

AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II

AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.

Ivashchenko Andrey Alexandrovich

AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II

Unraveling the Mechanism of Platelet Aggregation Suppression by Thioterpenoids: Molecular Docking and In Vivo Antiaggregant Activity

Nikitina, Liliya E., Bocharov, Pavel S., Ksenofontov, Alexander A., Antina, Elena V., Gilfanov, Ilmir R., Pavelyev, Roman S., Ostolopovskaya, Olga V., Fedyunina, Inna V., Azizova, Zulfiya R., Pestova, Svetlana V., Izmest’ev, Evgeniy S., Rubtsova, Svetlana A., Boichuk, Sergei V., Galembikova, Aigul R., Smolyarchuk, Elena A., Mustafin, Ilshat G., Kayumov, Airat R., Samorodov, Aleksandr V.

integrin, a well-known platelet GPIIb-IIIa receptor on platelets. We further examined the antiaggregant

Base-Catalyzed Reaction of Isatins and (3-Hydroxyprop-1-yn-1-yl)phosphonates as a Tool for the Synthesis of Spiro-1,3-dioxolane Oxindoles with Anticancer and Anti-Platelet Properties

Murashkina, Arina V., Bogdanov, Andrei V., Voloshina, Alexandra D., Lyubina, Anna P., Samorodov, Alexandr V., Mitrofanov, Alexander Y., Beletskaya, Irina P., Smolyarchuk, Elena A., Zavadich, Kseniya A., Valiullina, Zulfiya A., Nazmieva, Kseniya A., Korunas, Vladislav I., Krylova, Irina D.

Base-Catalyzed Reaction of Isatins and (3-Hydroxyprop-1-yn-1-yl)phosphonates as a Tool

Results of Preclinical Studies of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1,2,4-triazole-4-th Bromide in Relation to the Hemostasis System in vivo

Ванг, Ю., Булатова, Н. Р., Клен, Е. Э., Розит, Г. А., Никитина, И. Л., Смолярчук, Е. А., Завадич, К. А., Крылова, И. Д., Самородов, А. В., Wang, Yi, Bulatova, Nailya R., Klen, Elena E., Rozit, Galina A., Nikitina, Irina L., Smolyarchuk, Elena A., Zavadich, Ksenia A., Krylova, Irina D., Samorodov, Aleksandr V.

Adaptive design in clinical development of next-in-class drugs

Vostokova, N. V., Trakhtenberg, Y. A., Smolyarchuk, E. A., Svistunov, A. A., Serebrova, S. Y.

THE DYNAMICS OF INFLAMMATORY MARKERS IN COVID-19 PATIENTS TREATED WITH LEVILIMAB

Lomakin, N, Bakirov, B, Musaev, G, Protsenko, D, Moiseeva, O, Pasechnik, E, Popov, V, Smolyarchuk, E, Gordeev, I, Gilyarov, M, Fomina, D, Mazurov, V, Morozova, M, Dokukina, E, Bogdan, D, Lutskii, A, Zinkina-Orihan, A, Linkova, I, Seleznev, A

Russia''s evil genius (К. P. Pobedonostsev)

Smolyarchuk V.I.

Safety and immunogenicity of the gamtbvac, the recombinant subunit tuberculosis vaccine candidate: A phase II, multi-center, double-blind, randomized, placebo-controlled study

Tkachuk A.P., Bykonia E.N., Popova L.I., Kleymenov D.A., Semashko M.A., Chulanov V.P., Fitilev S.B., Maksimov S.L., Smolyarchuk E.A., Manuylov V.A., Vasina D.V., Gushchin V.A., Gintsburg A.L.

GamTBvac is a candidate tuberculosis vaccine with two fusion proteins, containing Ag85a, ESAT6, CFP

Adaptive design in clinical development of next-in-class drugs

Vostokova, N. V., Trakhtenberg, Y. A., Smolyarchuk, E. A., Svistunov, A. A., Serebrova, S. Y.

Страница 1 из 29638